VTRLY (Vitrolife AB) Cyclically Adjusted Book per Share: $7.68 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VTRLY Vitrolife AB VTRLY
66 GF Score
Price $9.50
GF Value $18.72
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Vitrolife AB Cyclically Adjusted Book per Share?

Vitrolife AB VTRLY 66 Cyclically Adjusted Book per Share is $7.68 as of Jun. 2026. GuruFocus rates VTRLY with a GF Score™ of 66/100 and a GF Value™ of $18.72 (Possible Value Trap). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Vitrolife AB's adjusted book value per share for the three months ended in Jun. 2026 was $6.310. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $7.68 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Vitrolife AB's average Cyclically Adjusted Book Growth Rate was 11.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 28.10% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 47.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Vitrolife AB was 66.00% per year. The lowest was 20.50% per year. And the median was 41.80% per year.

As of today (2026-07-29), Vitrolife AB's current stock price is $9.50. Vitrolife AB's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was $7.68. Vitrolife AB's Cyclically Adjusted PB Ratio of today is 1.24.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Vitrolife AB was 53.22. The lowest was 1.39. And the median was 20.78.


Vitrolife AB  (OTCPK:VTRLY) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Vitrolife AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=9.50/7.68
=1.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Vitrolife AB was 53.22. The lowest was 1.39. And the median was 20.78.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Vitrolife AB Cyclically Adjusted Book per Share Related Terms


Vitrolife AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Vitrolife AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitrolife AB Cyclically Adjusted Book per Share Chart

Vitrolife AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.46 2.88 2.78 4.39 6.41

Vitrolife AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.86 6.61 6.41 6.96 7.68

VTRLY vs ABT, SYK, MDT: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, Vitrolife AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vitrolife AB Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Vitrolife AB's Cyclically Adjusted PB Ratio falls into.


VTRLY
66GF Score
Vitrolife AB VTRLY
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vitrolife AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vitrolife AB's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=6.31/134.1100*134.1100
=6.310

Current CPI (Jun. 2026) = 134.1100.

Vitrolife AB Quarterly Data

Book Value per Share CPI Adj_Book
201609 1.030 101.138 1.366
201612 1.019 102.022 1.340
201703 1.110 102.022 1.459
201706 1.154 102.752 1.506
201709 1.309 103.279 1.700
201712 1.346 103.793 1.739
201803 1.485 103.962 1.916
201806 1.405 104.875 1.797
201809 1.451 105.679 1.841
201812 1.523 105.912 1.928
201903 1.580 105.886 2.001
201906 1.567 106.742 1.969
201909 1.636 107.214 2.046
201912 1.752 107.766 2.180
202003 1.799 106.563 2.264
202006 1.864 107.498 2.325
202009 2.035 107.635 2.536
202012 2.217 108.296 2.745
202103 2.328 108.360 2.881
202106 2.355 108.928 2.899
202109 4.929 110.338 5.991
202112 12.445 112.486 14.837
202203 11.986 114.825 13.999
202206 11.755 118.384 13.317
202209 11.089 122.296 12.160
202212 11.906 126.365 12.636
202303 11.990 127.042 12.657
202306 12.119 129.407 12.559
202309 11.609 130.224 11.955
202312 9.157 131.912 9.310
202403 9.382 132.205 9.517
202406 9.219 132.716 9.316
202409 9.482 132.304 9.611
202412 9.167 132.987 9.244
202503 9.563 132.825 9.656
202506 10.269 133.699 10.301
202509 10.477 133.480 10.526
202512 6.271 133.390 6.305
202603 6.394 133.560 6.420
202606 6.310 134.110 6.310

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $7.68 mean?
Vitrolife AB (VTRLY) has a Cyclically Adjusted Book per Share of $7.68 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Vitrolife AB and its competitors.
Is Vitrolife AB's Cyclically Adjusted Book per Share too high?
Vitrolife AB's current Cyclically Adjusted Book per Share is $7.68. Overall, Vitrolife AB has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vitrolife AB's Cyclically Adjusted Book per Share compare to ABT and SYK?
Vitrolife AB's Cyclically Adjusted Book per Share of $7.68 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Vitrolife AB and its competitors. Vitrolife AB's current Cyclically Adjusted Book per Share is $7.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitrolife AB stock overvalued right now?
Based on GuruFocus' analysis, Vitrolife AB (VTRLY) is currently considered Possible Value Trap. The stock's GF Value™ is $18.72, compared to a current price of $9.50 — trading 49.3% below its estimated fair value. The current Cyclically Adjusted Book per Share is $7.68. Vitrolife AB's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Vitrolife AB (VTRLY), the current Cyclically Adjusted Book per Share is $7.68 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vitrolife AB (VTRLY) Overvalued in 2026?

Based on GuruFocus' analysis, Vitrolife AB stock appears to be undervalued. The current stock price of $9.50 is trading 49.3% below its estimated GF Value™ of $18.72. GuruFocus considers Vitrolife AB to be Possible Value Trap.

Key valuation signals for VTRLY:

  • Cyclically Adjusted Book per Share: $7.68
  • GF Value™: $18.72 vs. price of $9.50 (49.3% below fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the VTRLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vitrolife AB Business Description

Address Box 9080, Gothenburg, SWE, 400 92
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The company has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.
66GF Score

Get the complete analysis for VTRLY

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.50
Price
$18.72
GF Value